Evaluation of STD Programs’ Deployment of DIS to Improve HIV Outcomes | CDC RFA PS15 151102CONT16

Opportunity Information: Apply for CDC RFA PS15 151102CONT16

The grant opportunity titled "Evaluation of STD Programs' Deployment of DIS to Improve HIV Outcomes" is a CDC continuation funding notice issued as a cooperative agreement under Funding Opportunity Number CDC-RFA-PS15-151102CONT16. It sits within the health funding activity category and is associated with CFDA number 93.977. The purpose is not to launch a new competitive round of awards, but to extend or continue support for work that was already started under the earlier CDC announcement CDC-RFA-PS15-1511, which focused on evaluating how STD programs deploy Disease Intervention Specialists (DIS) to improve HIV-related outcomes.

This continuation is explicitly limited to prior recipients of the original PS15-1511 award, meaning eligibility is restricted to organizations that were already funded under that earlier program. In practical terms, it is meant to maintain momentum for existing evaluation activities rather than bring in new applicants, new jurisdictions, or new project designs. The listing labels eligible applicants broadly as "Others," but the controlling condition is that only previously awarded grantees under the referenced CDC-RFA-PS15-1511 can receive these continuation funds.

The overall program theme centers on the role of DIS within STD prevention programs and how their work can be used or adapted to support better HIV outcomes. DIS are commonly involved in partner services, case investigation, linkage to care, and related field-based public health activities. By funding evaluation of how STD programs deploy DIS, the CDC is aiming to generate evidence about which staffing models, workflows, and intervention approaches are most effective at improving outcomes along the HIV prevention and care continuum, such as identifying people with HIV, linking newly diagnosed individuals to care, re-engaging people who are out of care, and supporting partner notification or referral to prevention services where appropriate.

Administratively, the opportunity is categorized as a continuation and uses a cooperative agreement mechanism, which typically indicates substantial federal involvement beyond a standard grant. Under a cooperative agreement structure, the CDC often collaborates with funded recipients through ongoing technical assistance, shared planning, and coordinated evaluation expectations, rather than simply providing funds and receiving periodic reports.

Key dates and basic funding details provided in the source information include a creation date of March 23, 2016, and an original closing date of June 16, 2016. The award ceiling is listed as 0, which usually signals that a specific maximum amount is not stated in the public synopsis, that funding is determined by prior award terms, or that continuation amounts are governed by existing budget agreements and availability of funds rather than a new stated cap. The expected number of awards is not specified in the provided data, which is consistent with a continuation notice where the pool of eligible recipients is already known and limited to current grantees.

In short, this CDC notice is a continuation cooperative agreement intended to keep funding in place for existing grantees conducting evaluation work on how STD programs use Disease Intervention Specialists in ways that can measurably improve HIV outcomes. It is not an open competition and is designed to support ongoing, previously approved activities under the earlier PS15-1511 funding announcement.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Evaluation of STD Programs’ Deployment of DIS to Improve HIV Outcomes" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.977.
• This funding opportunity was created on 2016-03-23.
• Applicants must submit their applications by 2016-06-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA PS15 151102CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: